Pharma/Biotech – USA, Europe Regulatory News, Aug 2023 Vol. 1
US
FY 2024 Biosimilar User Fees Show Sharp Decrease, Other Fees Increase
While prescription drug user fees increased a hefty 19.9 percent and medical device fees a modest 8.7, fees for biosimilar...
Biotech Regulatory News, EU Regulatory News, marketing authorization, Pharma Regulatory News, post marketing requirements, Regulatory News, USA Regulatory News